Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pancreatic endocrine progenitor cell therapies for the treatment of obesity and type 2 diabetes (T2D)

Pancreatic endocrine progenitor cell therapies for the treatment of obesity and type 2 diabetes (T2D)

US Patent 10772917 · Granted Sep 15, 2020

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for regulated protein expression in gut2008